Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLEC11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC286437 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RPL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMEPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSL1D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G12A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SH2D2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGFBP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM104B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKI55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM218 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM261 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDR42E1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on